ANDREA ESSE: Open Payments
NPI 1518241090 · LUTZ, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,173 in 44 payments from 14 companies in 2025. Trend: 2023 $1,244 · 2024 $1,579 · 2025 $1,173
Food & beverage: $1,083Education: $90
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $465 |
| Galderma Laboratories, L.P. | 3 | $157 |
| Organon LLC | 5 | $134 |
| ABBVIE INC. | 3 | $68 |
| GENZYME CORPORATION | 3 | $67 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $65 |
| Lilly USA, LLC | 2 | $45 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
Products named: TREMFYA, NEMLUVIO, VTAMA, DUPIXENT, SKYRIZI, ILUMYA, TALTZ, Sotyktu.
Industry payments across FL — which companies pay providers there.
